Advertisement
Screener

NUWELLIS, INC. (NUWE) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

NUWELLIS, INC. Operating Cash Flow

NUWELLIS, INC. (NUWE) reported Operating Cash Flow of -$6.29 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13

  • NUWELLIS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$3.17M.
  • NUWELLIS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.11M.
  • NUWELLIS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$3.03M.
  • NUWELLIS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.15M.
  • NUWELLIS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$10.81M.
  • NUWELLIS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$9.59M.
  • NUWELLIS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$17.94M.
  • NUWELLIS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$15.15M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2026-06-30-$3.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$6.29M
10-Q · filed 2026-08-13
-$9.32M
derived: sum of 3 quarters · filed 2026-08-13
-$12.46M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$3.11M
10-Q · filed 2026-05-15
-$6.14M
derived: sum of 2 quarters · filed 2026-05-15
-$9.29M
derived: sum of 3 quarters · filed 2026-05-15
-$11.39M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31-$3.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11
-$6.18M
derived: sum of 2 quarters · filed 2026-03-11
-$8.27M
derived: sum of 3 quarters · filed 2026-08-13
-$10.81M
10-K · filed 2026-03-11
2025-09-30-$3.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$5.24M
derived: sum of 2 quarters · filed 2026-08-13
-$7.78M
10-Q · filed 2025-11-12
-$9.28M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30-$2.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$4.63M
10-Q · filed 2026-08-13
-$6.14M
derived: sum of 3 quarters · filed 2026-08-13
-$8.61M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$2.54M
10-Q · filed 2026-05-15
-$4.04M
derived: sum of 2 quarters · filed 2026-05-15
-$6.51M
derived: sum of 3 quarters · filed 2026-05-15
-$9.27M
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31-$1.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11
-$3.98M
derived: sum of 2 quarters · filed 2026-03-11
-$6.73M
derived: sum of 3 quarters · filed 2026-03-11
-$9.59M
10-K · filed 2026-03-11
2024-09-30-$2.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$5.22M
derived: sum of 2 quarters · filed 2025-11-12
-$8.09M
10-Q · filed 2025-11-12
-$10.84M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30-$2.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
-$5.62M
10-Q · filed 2025-08-14
-$8.37M
derived: sum of 3 quarters · filed 2025-08-14
-$12.20M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$2.86M
10-Q · filed 2025-05-13
-$5.62M
derived: sum of 2 quarters · filed 2025-05-13
-$9.44M
derived: sum of 3 quarters · filed 2025-05-13
-$14.69M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31-$2.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
-$6.58M
derived: sum of 2 quarters · filed 2025-03-11
-$11.83M
derived: sum of 3 quarters · filed 2025-03-11
-$17.94M
10-K · filed 2025-03-11
2023-09-30-$3.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$9.08M
derived: sum of 2 quarters · filed 2024-11-12
-$15.18M
10-Q · filed 2024-11-12
-$18.31M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$5.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
-$11.36M
10-Q · filed 2024-08-13
-$14.48M
derived: sum of 3 quarters · filed 2024-08-13
-$17.74M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31-$6.11M
10-Q · filed 2024-05-08
-$9.23M
derived: sum of 2 quarters · filed 2024-05-08
-$12.49M
derived: sum of 3 quarters · filed 2024-05-08
-$16.43M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31-$3.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11
-$6.38M
derived: sum of 2 quarters · filed 2024-03-11
-$10.32M
derived: sum of 3 quarters · filed 2024-03-11
-$15.15M
10-K · filed 2024-03-11
2022-09-30-$3.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$7.20M
derived: sum of 2 quarters · filed 2023-11-07
-$12.02M
10-Q · filed 2023-11-07
-$16.18M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30-$3.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$8.77M
10-Q · filed 2023-08-08
-$12.92M
derived: sum of 3 quarters · filed 2023-08-08
-$17.41M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31-$4.83M
10-Q · filed 2023-05-09
-$8.98M
derived: sum of 2 quarters · filed 2023-05-09
-$13.47M
derived: sum of 3 quarters · filed 2023-05-09
-$17.29M
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31-$4.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03
-$8.64M
derived: sum of 2 quarters · filed 2023-03-03
-$12.46M
derived: sum of 3 quarters · filed 2023-03-03
-$17.84M
10-K · filed 2023-03-03
-$17.88M
10-K · filed 2022-03-03
2021-09-30-$4.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
-$8.31M
derived: sum of 2 quarters · filed 2022-11-08
-$13.69M
10-Q · filed 2022-11-08
-$17.10M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30-$3.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
-$9.20M
10-Q · filed 2022-08-11
-$12.61M
derived: sum of 3 quarters · filed 2022-08-11
-$17.01M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$5.38M
10-Q · filed 2022-05-12
-$8.79M
derived: sum of 2 quarters · filed 2022-05-12
-$13.19M
derived: sum of 3 quarters · filed 2022-05-12
-$16.46M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$3.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
-$7.81M
derived: sum of 2 quarters · filed 2022-03-03
-$11.08M
derived: sum of 3 quarters · filed 2022-03-03
-$16.57M
10-K · filed 2022-03-03
2020-09-30-$4.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
-$7.67M
derived: sum of 2 quarters · filed 2021-11-10
-$13.16M
10-Q · filed 2021-11-10
-$17.19M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30-$3.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$8.76M
10-Q · filed 2021-08-12
-$12.79M
derived: sum of 3 quarters · filed 2021-08-12
-$16.25M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$5.50M
10-Q · filed 2021-05-13
-$9.53M
derived: sum of 2 quarters · filed 2021-05-13
-$12.99M
derived: sum of 3 quarters · filed 2021-05-13
-$16.95M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31-$4.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
-$7.49M
derived: sum of 2 quarters · filed 2021-03-25
-$11.46M
derived: sum of 3 quarters · filed 2021-03-25
-$16.37M
10-K · filed 2021-03-25
2019-09-30-$3.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
-$7.43M
derived: sum of 2 quarters · filed 2020-11-12
-$12.34M
10-Q · filed 2020-11-12
-$15.05M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30-$3.97M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
-$8.87M
10-Q · filed 2020-08-05
-$11.59M
derived: sum of 3 quarters · filed 2020-08-05
-$14.96M
derived: sum of 4 quarters · filed 2020-08-05
2019-03-31-$4.91M
10-Q · filed 2020-05-14
-$7.62M
derived: sum of 2 quarters · filed 2020-05-14
-$10.99M
derived: sum of 3 quarters · filed 2020-05-14
-$14.43M
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31-$2.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05
-$6.08M
derived: sum of 2 quarters · filed 2020-03-05
-$9.52M
derived: sum of 3 quarters · filed 2020-03-05
-$14.56M
10-K · filed 2020-03-05
2018-09-30-$3.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$6.81M
derived: sum of 2 quarters · filed 2019-11-08
-$11.84M
10-Q · filed 2019-11-08
-$14.99M
derived: sum of 4 quarters · filed 2019-11-08
2018-06-30-$3.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$8.48M
10-Q · filed 2019-08-08
-$11.63M
derived: sum of 3 quarters · filed 2019-08-08
-$14.70M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31-$5.04M
10-Q · filed 2019-05-09
-$8.19M
derived: sum of 2 quarters · filed 2019-05-09
-$11.26M
derived: sum of 3 quarters · filed 2019-05-09
-$15.34M
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31-$3.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21
-$6.22M
derived: sum of 2 quarters · filed 2019-02-21
-$10.31M
derived: sum of 3 quarters · filed 2019-02-21
-$11.92M
10-K · filed 2019-02-21
2017-09-30-$3.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
-$7.16M
derived: sum of 2 quarters · filed 2018-11-07
-$8.77M
10-Q · filed 2018-11-07
-$11.50M
derived: sum of 4 quarters · filed 2018-11-07
2017-06-30-$4.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$5.70M
10-Q · filed 2018-08-09
-$8.43M
derived: sum of 3 quarters · filed 2018-08-09
-$12.85M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31-$1.61M
10-Q · filed 2018-05-10
-$4.34M
derived: sum of 2 quarters · filed 2018-05-10
-$8.77M
derived: sum of 3 quarters · filed 2018-05-10
2016-12-31-$2.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22
-$7.16M
derived: sum of 2 quarters · filed 2018-03-22
-$16.29M
10-K · filed 2018-03-22
2016-09-30-$4.43M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
-$13.56M
10-Q · filed 2017-11-02
2016-06-30-$9.14M
10-Q · filed 2017-08-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENDRA Life Sciences Inc. (NDRA)United States$0.009B
IRIDEX CORP (IRIX)United States$0.011B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Outset Medical, Inc. (OM)United States$0.059B-1.09
Streamex Corp. (STEX)United States$0.089B-0.19
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B